A. Reynaud-Bougnoux

1.1k citations

31 papers · 703 indexed · h-index 11

Oncology top 10%
Surgery top 10%
Pulmonary and Respiratory Medicine top 10%
Cancer Research top 10%
Pathology and Forensic Medicine top 10%

Co-authors: G. Calais O. Le Floch I. Barillot S. Chapet Philippe Bougnoux Christine Berger G. Body Étienne Dorval
Topics: Breast Cancer Treatment Studies (13 papers)Cancer Treatment and Pharmacology (7 papers)Advanced Radiotherapy Techniques (6 papers)
Cited by: Cancer Research Oncology Radiation
Journals: Journal of Clinical Oncology PLoS ONE Cancer
Partner nations: France

In The Last Decade

A. Reynaud-Bougnoux

28 papers receiving 686 citations

Peers

Countries citing papers authored by A. Reynaud-Bougnoux

Since Specialization

Citations

This map shows the geographic impact of A. Reynaud-Bougnoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Reynaud-Bougnoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Reynaud-Bougnoux more than expected).

Fields of papers citing papers by A. Reynaud-Bougnoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Reynaud-Bougnoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Reynaud-Bougnoux. The network helps show where A. Reynaud-Bougnoux may publish in the future.

Co-authorship network of co-authors of A. Reynaud-Bougnoux

This figure shows the co-authorship network connecting the top 25 collaborators of A. Reynaud-Bougnoux. A scholar is included among the top collaborators of A. Reynaud-Bougnoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Reynaud-Bougnoux. A. Reynaud-Bougnoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation 2019 ·PLoS ONE ·(unknown),Marie‐Laure Tanguy,Paul Cottu,Brigitte De La Lande,P. Bontemps,C. Lemanski,Pierre Baumann,Alexia Savignoni,Christelle Lévy,Karine Peignaux,A. Reynaud-Bougnoux,(unknown),Youlia Kirova	6
2	Grossesse après cancer du sein : revue de la littérature 2019 ·La Presse Médicale ·(unknown),A. Reynaud-Bougnoux,G. Body,Lobna Ouldamer	4
3	Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study 2018 ·Cancer/Radiothérapie ·(unknown),Lisa Belin,Paul Cottu,P. Bontemps,C. Lemanski,(unknown),Pierre Baumann,(unknown),Christelle Lévy,Karine Peignaux,A. Reynaud-Bougnoux,Fabrice Denis,(unknown),(unknown),Youlia Kirova	2
4	Abstract P1-10-17: Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer 2017 ·Cancer Research ·(unknown),Lisa Belin,Paul Cottu,P. Bontemps,C. Lemanski,(unknown),Pierre Baumann,(unknown),Christine Lévy,(unknown),A. Reynaud-Bougnoux,Fabrice Denis,(unknown),(unknown),Alain Fourquet,(unknown)	0
5	Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report 2016 ·Cancer/Radiothérapie ·(unknown),A. Reynaud-Bougnoux,(unknown),(unknown),Y. Pointreau,G. Calais	44
6	Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer 2015 ·British Journal of Radiology ·(unknown),Lisa Belin,P. Cottu,P. Bontemps,C. Lemanski,(unknown),Pierre Baumann,(unknown),Christelle Lévy,Karine Peignaux,A. Reynaud-Bougnoux,Fabrice Denis,(unknown),Marc A. Bollet,(unknown),R. Dendale,Frank Campana,Alain Fourquet,Youlia Kirova	9
7	Toxicité aiguë cutanée de l’irradiation mammaire avec modulation d’intensité avec technique de champ dans le champ (optimisation avec pré-segmentation) 2015 ·Cancer/Radiothérapie ·(unknown),(unknown),A. Reynaud-Bougnoux,I. Barillot	6
8	Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741). 2011 ·Journal of Clinical Oncology ·Bernard Dubray,V. Beckendorf,S. Guérif,É. Le Prisé,A. Reynaud-Bougnoux,(unknown),Thomas Nguyen,Christophe Hennequin,J Crétin,(unknown),(unknown),Jean‐Marc Bachaud,D. Azria,(unknown),P. Pommier,Jean-Marc Simon,Valentin Harter,Muriel Habibian,(unknown)	29
9	5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies 2011 ·European Journal of Cancer ·(unknown),(unknown),J. Provençal,Claire Cropet,(unknown),Valérie Delecroix,A. Reynaud-Bougnoux,J Crétin,Thomas Bachelot	5
10	Évaluation par le patient de la toxicité aiguë de la radiothérapie pelvienne selon la Common Terminology Criteria for Adverse Events, version 3.0 (CTCAE v3.0) : rêve ou réalité ? 2010 ·Cancer/Radiothérapie ·(unknown),A. Reynaud-Bougnoux,I. Barillot	119
11	Curiethérapie intracavitaire de débit pulsé guidée par IRM : résultats préliminaires chez 25 patientes traitées au centre hospitalier universitaire de Tours 2010 ·Cancer/Radiothérapie ·(unknown),Lobna Ouldamer,A. Reynaud-Bougnoux,I. Barillot	0
12	Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications 1997 ·International Journal of Radiation OncologyBiologyPhysics ·Christine Berger,A. De Muret,P. Garaud,S. Chapet,Pascal Bourlier,A. Reynaud-Bougnoux,Étienne Dorval,Loïc de Calan,N. Huten,O. Le Floch,G. Calais	156
13	Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study 1997 ·International Journal of Radiation OncologyBiologyPhysics ·G. Calais,Étienne Dorval,(unknown),Pascal Bourlier,(unknown),S. Chapet,A. Reynaud-Bougnoux,N. Huten,L. de Calan,(unknown),(unknown)	45
14	Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C 1996 ·European Journal of Cancer ·Christine Berger,S. Chapet,A. Reynaud-Bougnoux,(unknown),O. Le Floch,G. Calais	5
15	Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm 1994 ·Cancer ·G. Calais,Christine Berger,Philippe Descamps,S. Chapet,A. Reynaud-Bougnoux,G. Body,Philippe Bougnoux,J. Lansac,O. Le Floch	106
16	Disappearance of the in situ component: a criterion predictive of metastasis in breast cancer after local relapse 1992 ·Radiotherapy and Oncology ·B. Chauvet,(unknown),(unknown),G. Body,C. Le Péchoux,G. Calais,A. Reynaud-Bougnoux,Philippe Bougnoux,(unknown),O. Le Floch	3
17	Lymphadenectomy in the management of endometrial carcinoma stage I and II. Retrospective study of 155 cases 1990 ·Clinical Oncology ·G. Calais,Philippe Descamps,(unknown),A. Reynaud-Bougnoux,Philippe Bougnoux,J. Lansac,O. Le Floch	8
18	Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer 1990 ·International Journal of Radiation OncologyBiologyPhysics ·B. Chauvet,A. Reynaud-Bougnoux,G. Calais,(unknown),(unknown),Philippe Bougnoux,O. Le Floch	51
19	Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II 1990 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Philippe Descamps,G. Body,A. Reynaud-Bougnoux,J. Lansac,Philippe Bougnoux,O. Le Floch	25
20	Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation—5 year results 1990 ·British Journal of Radiology ·G. Calais,A. Reynaud-Bougnoux,(unknown),P Beutter,O. Le Floch	5

About A. Reynaud-Bougnoux

A. Reynaud-Bougnoux is a scholar working on Otorhinolaryngology, Cancer Research and Radiation, having authored 31 papers that have together received 703 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (7 papers) and Advanced Radiotherapy Techniques (6 papers). The work is most often cited by research in Cancer Research (208 citations), Oncology (333 citations) and Radiation (79 citations). A. Reynaud-Bougnoux has collaborated with scholars based in France. Frequent co-authors include G. Calais, O. Le Floch, I. Barillot, S. Chapet, Philippe Bougnoux, Christine Berger, G. Body, Étienne Dorval, J. Lansac and Pascal Bourlier. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact